Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Niki BioSolutions, Inc.
Niki BioSolutions has requested the immediate withdrawal of its Form F-3 registration statement, originally filed on January 16, 2026. The company is no longer a Foreign Private Issuer and has filed a Form S-3 to proceed with its offering instead. The F-3 registration statement was never declared effective, and no securities were sold under it.…more
Niki BioSolutions, Inc.
Niki BioSolutions, Inc. has filed a Form S-3 registration statement to offer up to $75 million in securities, including common stock, preferred stock, warrants, and debt securities. This filing serves as a shelf registration, carrying forward unsold securities from a previous F-3 registration statement.…more
Niki BioSolutions, Inc.
Niki BioSolutions (formerly Aptorum Group) finalized its merger with DiamiR Biosciences on July 20, 2026, alongside a 1-for-10 reverse stock split. The company now trades on Nasdaq under the ticker symbol 'NIKI'. DiamiR, the acquired entity, faces substantial doubt regarding its ability to continue as a going concern due to recurring operating losses and working capital deficiencies.…more
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
No news collected yet. New articles will appear here.